Skip to main navigation menu Skip to main content Skip to site footer

Cognitive Vulnerability in the Elderly Patients with Depression: Who is at Risk?

Abstract

Background. Depression among the elderly is one of the main causes of global disability and a decline in the quality of life. Late-life depressions often accompany cognitive impairments, which can persist after the end of the depressive phase. The identification of clinico-biological predictors of the development and progression of cognitive disorders is an urgent problem of modern research.

Objective — to study the influence of clinical and biological characteristics of patients with late-onset depression on cognitive functioning (clinical and follow-up study).

Material and methods. 51 patients aged 60 years and older with late-life depression who were treated in a gerontopsychiatric hospital were re-examined after 1 and 3 years. By the end of the inpatient treatment period, two groups of patients were identified: group 1 — without cognitive impairment in the structure of depression — 38 participants (74.5 %) and group 2 — 13 participants (25.5 %) — with subjective complaints of memory impairment. Subsequently, a comparative prospective follow-up of patients from the selected groups was carried out. The examination was conducted using clinical-psychopathological, psychometric, immunological and statistical methods and clinical follow-up.

Results. Patients with cognitive impairment (group 2), compared with group 1, differed in age at the time of examination (73.4 ± 7.7 and 67.8 ± 5.9 years, respectively, p < 0.05), the psychopathological structure of depression (depression with predominant negative affectivity occurred in 76.9 and 55.3 % of cases, respectively, p < 0.05), the burden of multiple comorbidities, including cardiac pathology (100 and 76.3 % of cases, respectively, p < 0.05), lower efficacy of therapy (p < 0.001). In addition, the compared groups differed in immunological characteristics: all patients with complaints of memory impairment belonged to immunophenotype 2 (with reduced activity of leukocyte elastase and its protease inhibitor).

Conclusion. The study revealed a high risk of cognitive impairment in elderly patients with depression, which was associated with certain clinical and biological characteristics. The study revealed the following predictors of cognitive decline: the older age of patients, the predominance of negative affectivity in the structure of depression, multiple comorbidities, incomplete remissions, and features of the immune status.

Keywords

depression, cognitive functioning, clinical and biological features, older age, predictors of cognitive decline

PDF (Русский)

References

  1. Huang C., Fang Y., Yan F. et al. Efficacy of problem-solving therapy in treating late-life depression with potential cognitive impairment: A systematic review and meta-analysis // BMJ Open. – 2024. – Vol. 14, № 10. – e084130. – https://doi.org/10.1136/bmjopen-2024-084130
  2. Rhee T.G., Shim S.R., Manning K.J. et al. Neuropsychological assessments of cognitive impairment in major depressive disorder: A systematic review and meta-analysis with metaregression // Psychotherapy and Psychosomatics. – 2024. – Vol. 93. – Pp. 8–23. – https://doi.org/10.1159/000535665
  3. Knight M.J., Baune B.T. Cognitive dysfunction in major depressive disorder // Current Opinion in Psychiatry. – 2018. – Vol. 31. – Pp. 26–31. – https://doi.org/10.1097/YCO.0000000000000378
  4. Siddarth P., Funes C.M., Laird K.T. et al. Predictors of cognitive improvement following treatment for late-life depression // Journal of Geriatric Psychiatry and Neurology. – 2021. – Vol. 34. – Pp. 162–168. – https://doi.org/10.1177/0891988720915515
  5. Koenig A.M., Bhalla R.K., Butters M.A. Cognitive functioning and late-life depression // Journal of the International Neuropsychological Society. – 2014. – Vol. 20, № 5. – Pp. 461–467. – https://doi.org/10.1017/S1355617714000198
  6. Сафарова Т.П., Яковлева О.Б., Андросова Л.В. и др. Некоторые факторы воспаления и иммунофенотипы при депрессиях у пожилых больных // Журнал неврологии и психиатрии имени С.С. Корсакова. – 2020. – № 120 (2). – С. 53–58. – https://doi.org/10.17116/jnevro202012002153
  7. Safarova T.P., Yakovleva O.B., Androsova L.V. et al. Nekotorye faktory vospaleniya i immunofenotipy pri depressiyakh u pozhilykh bol’nykh // Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. – 2020. – № 120 (2). – S. 53–58. – https://doi.org/10.17116/jnevro202012002153
  8. Смулевич А.Б. Депрессии при соматических и психических заболеваниях. – М.: Медицинское информационное агентство, 2003. – 432 с.
  9. Smulevich A.B. Depressii pri somaticheskikh i psikhicheskikh zabolevaniyakh. – M.: Meditsinskoe informatsionnoe agentstvo, 2003. – 432 s.
  10. Frank E., Prien R.F., Jarrett R.B., Keller M.D., Kupfer D.J., Lavori P.W., Rush A.J., Weissman M.M. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence // Archives of General Psychiatry. – 1991. – Vol. 48, № 9. – Pp. 851–855. – https://doi.org/10.1001/archpsyc.1991.01810330075011
  11. Wiels W., Baeken C., Engelborghs S. Depressive symptoms in the elderly – an early symptom of dementia? A systematic review // Frontiers in Pharmacology. – 2020. – Vol. 11. – Art. 3422. – https://doi.org/10.3389/fphar.2020.0003422
  12. Kaup A.R., Byers A.L., Falvey C. et al. Trajectories of depressive symptoms in older adults and risk of dementia // JAMA Psychiatry. – 2016. – Vol. 73, № 5. – Pp. 525–531. – https://doi.org/10.1001/jamapsychiatry.2016.0004
  13. Panza F., Frisardi V., Capurso C. et al. Late-life depression, mild cognitive impairment, and dementia: Possible continuum? // American Journal of Geriatric Psychiatry. – 2010. – Vol. 18, № 2. – Pp. 98–116. – https://doi.org/10.1097/JGP.0b013e3181b0fa13
  14. Mourao R.J., Mansur G., Malloy-Diniz L.F. et al. Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: Systematic review and meta-analysis // International Journal of Geriatric Psychiatry. – 2016. – Vol. 31, № 8. – Pp. 905–911. – https://doi.org/10.1002/gps.4406
  15. Vares E.A., Salum G.A., Spanemberg L. et al. Depression dimensions: Integrating clinical signs and symptoms from the perspectives of clinicians and patients // PLoS ONE. – 2015. – Vol. 10, № 8. – e0136037. – https://doi.org/10.1371/journal.pone.0136037
  16. Lanctot K.L., Agüera-Ortiz L., Brodaty H. et al. Apathy associated with neurocognitive disorders: Recent progress and future directions // Alzheimer's & Dementia. – 2017. – Vol. 13, № 1. – Pp. 84–100. – https://doi.org/10.1016/j.jalz.2016.05.008
  17. Montoya-Murillo G., Ibarretxe-Bilbao N., Pena J. et al. The impact of apathy on cognitive performance in the elderly // International Journal of Geriatric Psychiatry. – 2019. – Vol. 34, № 5. – Pp. 657–665. – https://doi.org/10.1002/gps.5062
  18. Li N., Chen G., Zeng P. et al. Prevalence and factors associated with mild cognitive impairment among Chinese older adults with depression // Geriatrics & Gerontology International. – 2018. – Vol. 18, № 2. – Pp. 263–268. – https://doi.org/10.1111/ggi.13171
  19. Wu Z., Su G., Lu W. et al. Clinical symptoms and their relationship with cognitive impairment in elderly patients with depressive disorder // Frontiers in Psychiatry. – 2022. – Vol. 13. – Art. 1009653. – https://doi.org/10.3389/fpsyt.2022.1009653
  20. Zhong X., Wu Z., Ouyang C. et al. Cardiovascular diseases and related risk factors accelerated cognitive deterioration in patients with late-life depression: A one-year prospective study // International Psychogeriatrics. – 2019. – Vol. 31, № 10. – Pp. 1483–1489. – https://doi.org/10.1017/S1041610218002041
  21. Wu A., Zhang J. Neuroinflammation, memory, and depression: New approaches to hippocampal neurogenesis // Journal of Neuroinflammation. – 2023. – Vol. 20, № 1. – Art. 283. – https://doi.org/10.1186/s12974-023-02964-x
  22. Jiang P., Gao Y., Wang L. et al. Factors influencing cognitive function in elderly patients with late-life depression: A scoping review // Brain and Behavior. – 2025. – Vol. 15, № 1. – e70265. – https://doi.org/10.1002/brb3.70265
  23. Касьянова А.А., Лиманкин О.В., Петрова Н.Н. Противовоспалительная терапия биполярного аффективного расстройства: текущий уровень доказательств // Современная терапия психических расстройств. – 2025. – № 1. – С. 24–32. – https://doi.org/10.48612/psyph/p3n7-t14h-zdea
  24. Kas’yanova A.A., Limankin O.V., Petrova N.N. Protivovospalitel’naya terapiya bipolyarnogo affektivnogo rasstroystva: tekushchiy uroven’ dokazatel’stv // Sovremennaya terapiya psikhicheskikh rasstroystv. – 2025. – № 1. – S. 24–32. – https://doi.org/10.48612/psyph/p3n7-t14h-zdea
  25. Янушко М.Г., Шаманина М.В. Факторы нейровоспаления и когнитивный дефицит при рекуррентной депрессии: поиски патогенетических и терапевтических мишеней // Современная терапия психических расстройств. – 2024. – № 4. – С. 22–28. – https://doi.org/10.21265/PSYPH.2024.61.34.003
  26. Yanushko M.G., Shamanina M.V. Faktory neyrovosпалeniya i kognitivnyy defitsit pri rekurrentnoy depressii: poiski patogeneticheskikh i terapevticheskikh misheney // Sovremennaya terapiya psikhicheskikh rasstroystv. – 2024. – № 4. – S. 22–28. – https://doi.org/10.21265/PSYPH.2024.61.34.003
  27. Mars J.A., Marwaha R. Depressive cognitive disorders // StatPearls [Internet]. – Treasure Island (FL): StatPearls Publishing, 2025. – PMID: 32644682

Downloads

Download data is not yet available.